It is thought that CAIX ECD from tumour cells in response to chemotherapy is likely to have a dual-action, in which the effectiveness of the cytotoxic drug is reflected by an apoptosis-associated increase in CAIX ECD shedding which can be used as an indicator for the chemotherapy response. Here, CA9 is linked to neoplasm.